320 SOQUEL WAY, SUNNYVALE, CA
Market cap: $7.4M (12/23/2025)
Price: $1.27
Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA
Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno
Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality
Reports Third Quarter 2025 Business Highlights and Financial Results
Henry Ford Health Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial
University of Wisconsin Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial
Shareholder Director Nominations
Regains Compliance with Nasdaq Listing Requirements
Q3
Amended Quarterly Report
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload